Related Experiment Video
Updated: Jul 25, 2026

10:28
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
11.1K
Molecular features and prognostic factors of locally advanced microsatellite instability-high gastric cancer
Kenichiro Furukawa1, Keiichi Hatakeyama2, Masanori Terashima3
1Division of Gastric Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
Summary
Microsatellite instability-high (MSI-H) gastric cancer has distinct molecular features. Surgery plus S-1 chemotherapy and a T cell-inflamed gene signature may improve survival in these patients.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Microsatellite instability-high (MSI-H) tumors represent a distinct molecular subtype of gastric cancer.
- Limited comprehensive data exists on MSI-H tumors in locally advanced gastric cancer regarding molecular features and prognostic factors.
Purpose of the Study:
- To elucidate the molecular characteristics of locally advanced MSI-H gastric cancer.
- To identify prognostic factors influencing survival in this patient group.
Main Methods:
- Analysis of 499 locally advanced gastric cancer patients undergoing radical gastrectomy.
- Evaluation of MSI status and comparison with existing sequencing and gene expression data.
- Comparison of clinicopathological and molecular profiles between MSI-H and microsatellite-stable (MSS) gastric cancer patients.
Main Results:
- MSI-H tumors (15.8%) exhibited increased tumor mutational burden, MLH1 downregulation, PD-L1 upregulation, and cell cycle pathway enrichment.
- Disease-specific survival (DSS) was improved with surgery plus S-1 adjuvant chemotherapy, particularly in stage III MSI-H patients.
- Higher DSS was observed in the T cell-inflamed gene expression signature-high group, while the non-solid type poorly differentiated adenocarcinoma group showed worse DSS.
Conclusions:
- The study clarifies molecular features and prognostic factors for locally advanced MSI-H gastric cancer.
- S-1 adjuvant chemotherapy shows potential benefit.
- T cell-inflamed gene expression signature and histopathological type are significant prognostic factors for MSI-H tumors.

